Copyright
©The Author(s) 2021.
World J Gastrointest Oncol. Dec 15, 2021; 13(12): 2161-2179
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2161
Published online Dec 15, 2021. doi: 10.4251/wjgo.v13.i12.2161
JGCA2017 | JGCA | Becker | AJCC/CAP | Mandard | Modified | |
Overall survival | ||||||
JGCA2017 | 1.000 | 0.308 | 0.006 | 0.018 | 0.053 | < 0.001 |
JGCA | 1.000 | 0.007 | 0.021 | 0.063 | < 0.001 | |
Becker | 1.000 | 0.397 | 0.148 | 0.073 | ||
AJCC/CAP | 1.000 | 0.039 | 0.062 | |||
Mandard | 1.000 | 0.005 | ||||
Modified | 1.000 | |||||
Disease-free survival | ||||||
JGCA2017 | 1.000 | 0.320 | 0.002 | 0.021 | 0.033 | < 0.001 |
JGCA | 1.000 | 0.003 | 0.025 | 0.040 | < 0.001 | |
Becker | 1.000 | 0.273 | 0.136 | 0.046 | ||
AJCC/CAP | 1.000 | 0.112 | 0.024 | |||
Mandard | 1.000 | 0.002 | ||||
Modified | 1.000 |
- Citation: Liu ZN, Wang YK, Zhang L, Jia YN, Fei S, Ying XJ, Zhang Y, Li SX, Sun Y, Li ZY, Ji JF. Comparison of tumor regression grading systems for locally advanced gastric adenocarcinoma after neoadjuvant chemotherapy. World J Gastrointest Oncol 2021; 13(12): 2161-2179
- URL: https://www.wjgnet.com/1948-5204/full/v13/i12/2161.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v13.i12.2161